Life Sciences and Healthcare

Physician practice ownership set for radical change as COVID-19 strains finances

The COVID-19 pandemic is fundamentally changing healthcare delivery in the United States, from the acceptance of virtual physician visits to payment reform, and from the consolidation of integrated delivery networks to the very survival of independent physician practices. Clarivate market access expert Heather Johnson discusses how physician practice ownership is expected to evolve due to the pandemic. […]

Telehealth here to stay as unprecedented times drive innovation

The COVID-19 pandemic is fundamentally changing healthcare delivery in the United States. Clarivate market access expert Valerie Pillo discusses where the telehealth market is heading post-pandemic.   Telehealth has played a critical role in healthcare delivery during the COVID-19 pandemic, advancing its capabilities years ahead of its expected trajectory. It will likely become an integral part of […]

Hospital infections dip during pandemic

  Effect on COVID-19 and lockdown measures in the United States on hospital-acquired or hospital-treated infection shows stark contrast compared to the same period in 2019   Our analysis U.S. claims data shows that the number of admissions with hospital-acquired or hospital-treated infections between April-May 2019 and the same period in 2020 have dropped sharply […]

Key ESMO Highlights 2020

As a result of the current COVID-19 pandemic, the annual ESMO Congress was held virtually between 19th and 21st September 2020. Over 2,100 oral presentations and posters were presented, showcasing exciting novel data across oncology, with the ultimate aim of improving cancer patient care. Here DRG/Clarivate highlights the most impactful presentations on drug treatment landscapes. […]

GSK’s first-in-class anti-BCMA therapy wins regulatory approval

GSK’s BLENREP has become the first anti-BCMA therapy to secure a position in the treatment algorithm of multiple myeloma (relapsed or refractory setting). This approval was a highly anticipated event and significant for the multiple myeloma treatment landscape because it helps address an important unmet need for patients who have received at least four prior […]

Resilient supply chain requires geographic diversity

Manufacturing location is vital to securing the biopharma supply chain – for the finished product, APIs and the raw materials. How vulnerable are we?   “There’s a difference in knowing something and realizing something. We’ve known for quite a while now that we’re too dependent on other countries for our medical supplies. But during this […]

Identifying and evaluating new products to rise above the competition

Learn how the Business Development and Licensing team help Par Pharmaceutical rise above the competition by quickly and accurately identifying a shortlist of potential portfolio candidates, recognizing potential barriers to market entry, and monitoring the launch, API development and patenting activities of competitors worldwide.

Making data driven decisions with reliable intelligence

Johnson & Johnson experienced difficulties keeping up to date on the global drug pipeline and spent considerable time and expense gathering and analyzing data from multiple sources. Discover how Cortellis Competitive Intelligence helped the company apply reliable data to confidently make strategic decisions.

Aducanumab: On the verge of making history in Alzheimer’s disease

When Biogen and Eisai terminated aducanumab’s Phase III program in early Alzheimer’s disease (AD) for futility in March 2019, a mere two months after Roche discontinued crenezumab, we wondered if it was the end of the line for anti-beta amyloid (Aβ) treatment in symptomatic AD. Shortly after the announcement, we removed all late-phase anti-Aβ drugs […]

The future of continuous manufacturing in pharma

Batch processing has been the standard manufacturing method used by the pharma industry for the last 50 years. But recent advances in manufacturing technology have resulted in a faster, more efficient process known as continuous manufacturing. How do the two processes compare? And what are regulators saying?   The Food and Drug Administration (FDA) describes […]